Study of Two Digital Therapeutics for the Treatment of Experiential Negative Symptoms of Schizophrenia

Inclusion Criteria:

A participant will be eligible for entry into the study if all of the following criteria are met:

1. Has a primary diagnosis of schizophrenia.

2. Is on a stable dose of antipsychotic medication(s).

3. Has obtained an average score of ≥2 (moderate to severe) in at least two of thethree CAINS-MAP domains (Social, Work, or Recreational).

Exclusion Criteria:

A participant will not be eligible for study entry if any of the following criteria are met:

1. Is currently treated with more than two antipsychotic medications (including morethan two dosage forms).

2. Meets DSM-5, for diagnoses not under investigation.

3. Has participated in a CT-155 clinical study.